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ABSTRACT
ntroduction: Testing asymptomatic nipple discharge in women for occult hemoglobin to 
predict the presence of ductal carcinoma remains controversial. The purpose of this study is to 
describe the sensitivity and specificity of occult blood testing in patients with asymptomatic single 
duct nipple discharge. 
Methods: Data was collected ambispectively during a 7 year period. All patients with asymptoma-
tic single duct nipple discharge were included in this study. The results of occult blood testing were 
correlated with the histopathological results after microductectomy. 
Results: All 63 patients were female. They underwent mammography and ultrasound examina-
tion of the discharging breast which were normal in all cases. The average follow up period was 2 
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years (0.5 to 5 years). Occult blood was positive in 37 
(58.8 %) patients and negative in 26 (41.2 %) patients. 
Histopathological diagnosis was ductal ectasia in 30 % 
(n=18), intraductal papilloma in 44 % (n=28), gra-
nuloma 2 % (n=1), normal 12 % (n=8) and ductal 
carcinoma in situ 12 % (n=8). The most frequent cause 
for positive occult blood was ductal papilloma (n=23) 
followed by ductal ectasia (n=13). The sensitivity of the 
test was 87.5 % and specificity 45.4 %, with a positive 
predictive value of 18.9 % and a negative predictive va-
lue of 96.1 % and an Odds ratio of 5,833. 
Discussion: Positive occult blood testing can help to 
predict the presence of either in situ or invasive ductal 
carcinoma in the absence of other symptoms. We recom-
mend, however, an approach based on clinical exami-
nation, radiological testing and risk factor analysis to 
decide which patients require microductectomy to exclude 
the presence cancer definitively.
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RESUMEN
Introducción: la utilidad de la prueba de sangre 
oculta en la secreción patológica por el pezón 
en pacientes no lactantes para detectar cáncer 
de seno, es motivo de gran debate en la actuali-
dad. El propósito de este estudio fue describir la 
sensibilidad y especificidad de la prueba en esta 
población. 
Materiales y métodos: estudio de cohorte 
ambispectivo por un periodo de siete años. Se 
incluyeron pacientes con secreción patológica 
por el pezón, a quienes se les realizó prueba 
de sangre oculta y se obtuvieron características 
operativas de una prueba diagnóstica con los 
resultados histopatológicos luego de una micro-
ductectomía. 
Resultados: se obtuvo información de 63 pa-
cientes de sexo femenino. En todos los casos se 
realizaron mamografía y ultrasonido de mama, 
adicional al examen físico. El tiempo se segui-
miento fue en promedio de dos años (0,5 a 5 
años). La sangre oculta fue positiva en 58,8 % de 
las pacientes. Se obtuvo un resultado negativo 
(líquido claro) en 41,2 % de las pacientes. Los 
diagnósticos histopatológicos obtenidos fue-
ron: ectasia ductal 30 %, papiloma intraductal 
44 %, granuloma 2 %, normal 12 % y carcino-
ma ductal in situ 12 %. La causa más frecuente 
de sangre oculta positiva en la secreción fue el 
papiloma ductal (n=23) seguido por la ectasia 
ductal (n=13). La sensibilidad fue del 87,5 % y 
la especificidad del 45,4 %, el valor predictivo 
positivo fue 18,9 % y el valor predictivo negativo 
fue del 96,1 %, con un Odds Ratio de 5,8. 
Conclusiones: detectar sangre oculta en la se-
creción asintomática de un solo ducto del pezón 
puede ayudar a predecir la presencia de cáncer 
en los ductos mamarios. Sin embargo, recomen-
damos una aproximación basada en un algorit-
mo de decisiones utilizando una combinación 
de examen físico, pruebas de laboratorio e ima-
genología avanzada para detectar la presencia 
de malignidad en el tejido ductal.
PALABRAS CLAVE
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INTRODUCTION
Nipple discharge in a non-lactating patient can 
be troubling and lead to misinterpretation of 
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clinical findings by the treating physician. It is 
a common finding and is seldom associated to 
ductal cancer. In one of the first reports in 1982, 
Chaudary et al., found an incidence of cancer 
of 5.9 % in a total of 270 patients with this cli-
nical presentation (1). All cancer cases had po-
sitive occult blood on testing nipple discharge. 
When this occurs, further investigations should 
be sought out, like performing a mammogram, 
ultrasound and a ductal biopsy (microductec-
tomy). 
The incidence of finding cancer increases when 
nipple discharge is associated with other clinical 
findings such as palpable mass and positive ra-
diological findings (2). The most common cause 
for positive occult blood testing is, however, a 
ductal papilloma. 
Physiological causes of nipple discharge include 
galactorrhea, antihypertensive, oral contracepti-
ves, hypothyroidism, pituitary adenoma, exces-
sive nipple stimulation and hyperprolactinemia, 
and are usually bilateral, green colored and pro-
voked by stimulus. Pathological causes usually 
produce a clear, bloodstained, spontaneous and 
unilateral discharge most frequently caused by 
ductal ectasia or papilloma (3). 
There are numerous studies that have attemp-
ted to establish if there is a correlation between 
the type an color of the nipple discharge and the 
incidence of ductal cancer, and to date, no study 
has shown that discharge characteristics has a 
strong association with the presence of cancer 
(4,5). 
At present, the only pre-surgical test that has 
shown reliable results with excellent sensitivity 
and specificity is a galactography associated to 
traditional radiological imaging (6). This test is 
slightly cumbersome as it requires the someti-
mes painful cannulation of the secreting duct, 
injection of contrast material and subsequent 
radiological imaging with conventional X-ray or 
magnetic resonance imaging. 
The purpose of this study is to establish the sen-
sitivity and specificity of occult blood testing in 
patients with pathological nipple discharge with 
normal radiological and clinical tests.
MATERIALS AND 
METHODS
We conducted an ambispective cohort study in-
cluding patients form the Great Western Hospi-
tal in Swindon, UK, all which attended the Breast 
Unit during the period between January 2000 and 
December 2007. For this study we included a 
subgroup of patients with asymptomatic, single 
duct nipple discharge that had a normal clinical 
examination, normal mammogram and normal 
ultrasound examination. All demographic data 
including age at diagnosis, gender, type of dis-
charge were collected. Follow up was recorded 
for all patients, including radiological and clini-
cal examinations. 
Occult blood testing was performed using spon-
taneous discharge from the affected nipple with 
minimal manipulation, the sample was analyzed 
using a multireagent strip (Uristix)® to detect 
the presence of blood. The independent varia-
ble was a positive test result, and the dependent 
variable was the histopathological result of the 
microductectomy (gold standard).
All results from mammography, ultrasonography 
and clinical examination were collected. Patients 
with pathological nipple discharge who had a 
positive finding on either clinical examination or 
radiological examination were excluded from the 
study, as well as patients with physiological cau-
ses for nipple discharge.
All data was collected in an encrypted Excel da-
tabase. Descriptive statistics such as frequen-
cies and median ranges for all categorical va-
riables were obtained, as well as values for the 
test such as specificity, sensitivity, positive and 
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negative predictive values and the odds ratio for 
the 2x2 table. All analysis was calculated using 
the EpiMax Health Decision Strategies®, LLC, 
Princeton New Jersey, USA (www.healthstrategy.
com) online software. 
All patients gave their informed consent to use 
the data from their respective clinical charts. 
The data collected for this study had no influen-
ce on the decision making process for treatment 
of the patients as the departmental policy to 
operate all non-physiologic nipple secretions 
was well established before this study.
RESULTS
A total of 63 patients were included in this study, 
all with pathological, asymptomatic nipple dis-
charge. All patients were female, the median age 
was 52 years (range 24 to 94), and all underwent 
a physical examination which was normal in all 
cases, as well as all mammographies and ultra-
sound examinations. Mean time of follow up was 
2 years (0.5 to 5 years). All cases underwent a 
microductectomy and compared to the result of 
the occult blood testing.
All samples were analyzed histopathologically 
(gold standard) and the presence or absence of 
ductal carcinoma was sought out. We then com-
pared the results of this with the clinical findings 
previously. 
A positive occult blood test was found in 37 
(58.8 %) patients. In the patients with negative 
results, 38 % had clear fluid and two had either 
cream colored and green discharge respectively 
(3.18 %) (table 1).
Table 1. Demographic data
Demographic characteristics Patients (n=63) Complementary tests
Female n=63 Mammography R2 n=63
Age (Median) 52 (Range 24-94 years) Ultrasound U2 n=63
Occult blood test + 37 Physical Examination P2 n=63
Occult blood test - 26
Pathological Diagnosis
Ductal papilloma 28 (44 %)
Ductal ectasia 18 (30 %)
Normal 8 (12 %)
Granuloma 1 (2 %)
Ductal carcinoma in situ 8 (12 %)
Diagnosis obtained after histopathological 
analysis was ductal ectasia in 30 %, intraductal 
papilloma 44 %, granuloma 2 %, normal in 12 
% and ductal carcinoma in situ 12 %. Ages of 
patients with ductal carcinoma ranged from 37 
to 80 years. The most common cause for a po-
sitive occult blood test was a ductal papilloma 
(n=23, 36.5 %) followed by ductal ectasia 
(n=13, 20.63 %). In all cases who presented nor-
mal histopathological results or patients with 
granulomas the occult blood test was negative. 
In the cases with ductal carcinoma 7 tes-
ted positive to occult blood preoperatively 
(table 2).
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During follow up, two patients presented with 
ipsilateral malignant lesions de novo. In both ca-
ses ductal carcinoma in situ was the initial pre-
sentation. Unfortunately in one case the disease 
progressed and she required a total mastectomy 
and chemo-radiotherapy follow by her death af-
ter 5 years of treatment. The interesting finding 
in these cases is that the initial occult blood test 
was positive and an initial diagnosis of ductal 
ectasia was made. 
According to these results preoperative occult 
blood testing had a sensitivity of 87.5 % and a 
specificity of 45.4 % with a positive predictive 
value of 18.9 % and a negative predictive value 
of 96.1 % (Odds ratio: 5,83, and 95 % confiden-
ce interval: 0.636-137.16). The likelihood ratios 
(LR) were as follows: positive LR of 1.604 and a 
negative LR of 0.275. No complications were re-
corded that were directly caused by the micro-
ductectomy.
DISCUSSION
Additional diagnostic tools during clinical exa-
mination of a patient with pathological nipple 
discharge have improved in recent years. At pre-
sent it is imperative to use mammography and 
ultrasound to examine suspicious lesions or ma-
nifestations of breast disease. In our subgroup 
of patients, the situation is more complex, as 
none of them have positive findings with the 
accepted modes of diagnosis such as mammo-
graphy, ultrasound and clinical examination and 
additional diagnostic tools are thus necessary. 
Several other ways of analyzing nipple discharge 
have been proposed such as cytology of the dis-
charge and occult blood testing of the secretion 
(7-9). 
In 1990, Welch et al. published a study in which 
a group of 162 patients with pathological nipple 
discharge and no mammography were tested for 
occult blood. The results of this study showed 
an incidence of ductal carcinoma in situ (DCIS) 
of 10 % (n=16) in which the test was positive in 
14 patients. In two patients the test was negati-
ve and the color was clear. The initial recommen-
dation was to perform a microductectomy based 
on clinical findings rather than on the result of 
the test (7,8).
These results are comparable with our findings, 
in such that our incidence of ductal carcinoma 
was 12 % and that one patient had a negative 
occult blood test on examination. Later, seve-
ral groups have attempted to shed a better light 
on the matter, Wong et al., and Richards et al., 
published in 2000 and 2007 respectively, two re-
trospective studies comparing the color of the 
discharge with the presence of cancer.
In both studies the incidence of DCIS was 5 % 
and 2.3 % respectively, and in both positive oc-
cult blood testing was better correlated with the 
presence of ductal papilloma and ductal ectasia 
(10-12). The conclusion of both studies was that 
the color or presence of positive occult blood 
does not correlate or predict the occurrence of 
Table 2. Results of sensitivity and specificity analysis
Cancer No Cancer Totals Predictive value
Positive Test 7 30 37 18.0 %
Negative Test 1 25 26 96.1 %
Totals 8 (12 %) 55 (88 %) 63 (100 %)
Sensitivity:
87.5 %
Specificity:
45.4 %
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DCIS. They suggested using a decision making 
algorithm based on patient characteristics and 
risk factors. 
In the largest series reviewed, Florio et al. pu-
blished in 2003 their personal experience with 
2818 cases during a 21 year period. The results 
showed that nipple discharge was clear, dark, 
blood stained or watery. These findings were, 
however, more common in patients with ductal 
papillomas and other ductal inflammatory con-
ditions. The possibility of detecting DCIS was 
increased when clinical findings were comple-
mented with mammography, cytology and ga-
lactography, especially in patients older than 50 
years (13).
All results a very similar to those obtained in our 
study. The association between the presence of 
positive occult blood and DCIS was not strong, 
with a sensitivity of 87.5 % and a specificity of 
45.5 % ,showing that a positive test has to inter-
preted with caution, especially to make a deci-
sion whether to perform a microductectomy or 
not. However, the negative predictive value of 
96.1 % might help the clinician to make a more 
informed decision in this subgroup of patients 
wether to perform a microductectomy or not. 
Based on optimized breast cancer diagnostic 
and treatment models, two studies by Nelson 
RL et al. (2006) and Sauter (2006) suggest that 
patients should be stratified according to risk 
factors and clinical presentation, discharge co-
lor helped to increase the likelihood of finding 
DCIS, however, they recommended to perform 
a microductectomy in all patients with patholo-
gical nipple discharge (14,15). The same recom-
mendation was followed in this study.
One common observation of this and other stu-
dies is that no single diagnostic test is useful to 
predict the occurrence of DCIS. It is a combina-
tion of clinical history, examination and radiolo-
gical tests that offer the best possibility for de-
tecting early stages of cancer (16-18).
The role of cytology in detecting DCIS has been 
the target of multiple studies, the largest one 
offered by Gupta RK et al., in 2004, who proved 
that cytology had a high sensitivity to detect 
DCIS but a low specificity. Additionally, 20 % of 
samples where inadequate for interpretation for 
which a microductectomy was necessary (19). 
Differentiation of cells in a cytology specimen 
can be difficult due to the low volume of the 
sample and can be the cause for disagreement 
between pathologists. Because of this and the 
conflicting results of other studies (20,21), the 
cytological analysis of nipple discharge was not 
included in the present study.
Novel modalities such as ductoscopy and ga-
lactography promise to allow better preoperati-
ve testing for the presence of DCIS, especially 
when associated to traditional radiological tests. 
Reimer et al. in Rostcok, Germany, published a 
study in which all patients with pathological 
nipple discharge underwent a galactography 
and compared to histopathological results. The 
results showed an incidence of DCIS of 9.3 % 
in premenopausal and of 12.5 % in post-meno-
pausal women. Most interesting is the fact that 
correlation was 94.1 % between both methods 
and no additional clinical tests were used such 
as cytological or occult blood testing (22).
Finally, newer, less invasive methods are being 
developed such as biological markers in the dis-
charge fluid. In a recent study by Sauter et al., 
a significant correlation was found between the 
levels of basic fibroblast growth factor (bFGF) 
and the Fase S fraction (SPF) with the presence 
of DCIS (23). Still, the problem remains as these 
tests are not widely available and are too expen-
sive to be cost effective. Newer modalities such 
as magnetic resonance ductography and ultra-
sound glactography are in its evaluation phases 
and promise more specific ways of predicting 
carcinoma in mammary ducts (24, 25). 
The limitations of this study are the small num-
ber of patients to make a more powerful calcu-
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lation of the true value of occult blood testing in 
this scenario. But as other comparative studies 
suggest, the occurrence of patients within this 
subgroup is small, and other types of presenta-
tion of ductal carcinoma is far more common. 
CONCLUSIONS
The results show that with a positive occult blood 
test a physician can detect 1 in 5 DCIS and only 
a 1 in 26 chance of missing a potential cancer in 
situ. This can aid the treating specialist in wether 
or not to perform a microductectomy, especially 
in places were more advanced diagnostic tools 
are not available. We recommend however an 
approach based on clinical examination, radio-
logical testing and risk factor analysis to deci-
de which patients require microductectomy to 
exclude the presence cancer definitively. Future 
research of newer biological markers may prove 
to be more accurate as initial screening tools.
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